Symptomtext
52 years old female patient who received an expired dose of fluzone quadrivalent with no reported adverse event; Initial information received on 01-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 52 years old female patient who received an expired dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Oct-2022, the patient received expired dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UJ471AA) (expired product administered) (latency same day) (dose, formulation, strength, and expiry date: unknown) via intramuscular route in unknown administration site for flu (influenza). Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) was not applicable. At time of reporting, the outcome was Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.